78 related articles for article (PubMed ID: 2187118)
1. Identification of TNF-LT blocking factor(s) in the serum and ultrafiltrates of human cancer patients.
Gatanaga T; Lentz R; Masunaka I; Tomich J; Jeffes EW; Baird M; Granger GA
Lymphokine Res; 1990; 9(2):225-9. PubMed ID: 2187118
[TBL] [Abstract][Full Text] [Related]
2. Identification of tumor necrosis factor and lymphotoxin blocking factor(s) in the ascites of patients with advanced and recurrent ovarian cancer.
Cappuccini F; Yamamoto RS; DiSaia PJ; Grosen EA; Gatanaga M; Lucci JA; Ininns EK; Gatanaga T; Granger GA
Lymphokine Cytokine Res; 1991 Jun; 10(3):225-9. PubMed ID: 1653048
[TBL] [Abstract][Full Text] [Related]
3. Blocking factors (soluble membrane receptors) for tumor necrosis factor and lymphotoxin detected in ascites and released in short-term cultures obtained from ascites and solid tumors in women with gynecologic malignancy.
Grosen EA; Yamamoto RS; Ioli G; Ininns EK; Gatanaga M; Gatanaga T; DiSaia PJ; Berman M; Manetta A; Granger GA
Lymphokine Cytokine Res; 1992 Dec; 11(6):347-53. PubMed ID: 1335764
[TBL] [Abstract][Full Text] [Related]
4. Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque.
Raine CS; Bonetti B; Cannella B
Rev Neurol (Paris); 1998 Sep; 154(8-9):577-85. PubMed ID: 9809372
[TBL] [Abstract][Full Text] [Related]
5. Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients.
Gatanaga T; Hwang CD; Kohr W; Cappuccini F; Lucci JA; Jeffes EW; Lentz R; Tomich J; Yamamoto RS; Granger GA
Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8781-4. PubMed ID: 2174164
[TBL] [Abstract][Full Text] [Related]
6. The human LT system. XI. Identification of LT and "TNF-like" forms from stimulated natural killers, specific and nonspecific cytotoxic human T cells in vitro.
Yamamoto RS; Ware CF; Granger GA
J Immunol; 1986 Sep; 137(6):1878-84. PubMed ID: 2943806
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes.
Mackay F; Bourdon PR; Griffiths DA; Lawton P; Zafari M; Sizing ID; Miatkowski K; Ngam-ek A; Benjamin CD; Hession C; Ambrose CM; Meier W; Browning JL
J Immunol; 1997 Oct; 159(7):3299-310. PubMed ID: 9317128
[TBL] [Abstract][Full Text] [Related]
8. Measurement of the soluble membrane receptors for tumor necrosis factor and lymphotoxin in the sera of patients with gynecologic malignancy.
Grosen EA; Granger GA; Gatanaga M; Ininns EK; Hwang C; DiSaia P; Berman M; Manetta A; Emma D; Gatanaga T
Gynecol Oncol; 1993 Jul; 50(1):68-77. PubMed ID: 8394276
[TBL] [Abstract][Full Text] [Related]
9. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
Corcoran AE; Scallon BJ; Trinh H; Chernajovsky Y; Ghrayeb J; Feldmann M
Eur Cytokine Netw; 1998 Sep; 9(3):255-62. PubMed ID: 9831174
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system.
Warzocha K; Bienvenu J; Coiffier B; Salles G
Eur Cytokine Netw; 1995; 6(2):83-96. PubMed ID: 7578992
[TBL] [Abstract][Full Text] [Related]
11. Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro.
Abe Y; Gatanaga M; Osuka Y; Kimura S; Burger RA; Granger GA; Gatanaga T
J Immunol; 1993 Jun; 150(11):5070-9. PubMed ID: 8098725
[TBL] [Abstract][Full Text] [Related]
12. Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption.
Stashenko P; Dewhirst FE; Peros WJ; Kent RL; Ago JM
J Immunol; 1987 Mar; 138(5):1464-8. PubMed ID: 3492553
[TBL] [Abstract][Full Text] [Related]
13. Proinflammatory responses are efficiently induced by homotrimeric but not heterotrimeric lymphotoxin ligands.
Hochman PS; Majeau GR; Mackay F; Browning JL
J Inflamm; 1995-1996; 46(4):220-34. PubMed ID: 8878796
[TBL] [Abstract][Full Text] [Related]
14. Studies on the differing effects of tumor necrosis factor and lymphotoxin on the growth of several human tumor lines.
Browning J; Ribolini A
J Immunol; 1989 Sep; 143(6):1859-67. PubMed ID: 2550545
[TBL] [Abstract][Full Text] [Related]
15. Differences in the bioactivity of recombinant human TNF, LT, and T-cell-derived LT-3 on transformed cells in vitro and the Meth A tumor growing in BALB/c mice.
Granger GA; Masunaka I; Averbook B; Kobayashi M; Fitzgerald M; Yamamoto R
J Biol Response Mod; 1988 Oct; 7(5):488-97. PubMed ID: 3263472
[TBL] [Abstract][Full Text] [Related]
16. Lymphotoxin lacks effects on 75-kDa receptors in cytotoxicity on U-937 cells.
Iwamoto S; Shibuya I; Takeda K; Takeda M
Biochem Biophys Res Commun; 1994 Feb; 199(1):70-7. PubMed ID: 8123048
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor alpha and lymphotoxin stimulate human myeloblastic leukemia cell (ML-1) invasion through a reconstituted basement membrane (Matrigel) with concomitant induction of 92 kDa gelatinase secretion.
Kubota S; Takeda K; Yamada T; Nomura Y; Takeda M; Iwamoto S; Seyama Y
Cancer Lett; 1996 Jan; 98(2):233-40. PubMed ID: 8556714
[TBL] [Abstract][Full Text] [Related]
18. Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells.
Zipp F; Weber F; Huber S; Sotgiu S; Czlonkowska A; Holler E; Albert E; Weiss EH; Wekerle H; Hohlfeld R
Ann Neurol; 1995 Nov; 38(5):723-30. PubMed ID: 7486863
[TBL] [Abstract][Full Text] [Related]
19. Lymphotoxin-beta and TNF regulation in T cell subsets: differential effects of PGE2.
Ferreri NR; Millet I; Askari B; Magnani P; Ruddle NH
Cytokine; 1997 Mar; 9(3):157-65. PubMed ID: 9126704
[TBL] [Abstract][Full Text] [Related]
20. Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species.
Pober JS; Lapierre LA; Stolpen AH; Brock TA; Springer TA; Fiers W; Bevilacqua MP; Mendrick DL; Gimbrone MA
J Immunol; 1987 May; 138(10):3319-24. PubMed ID: 3494766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
